[PDF][PDF] Stem cells: a promising therapeutic target for COVID-19

TH Leyla, X Nan - Stem Cell Discovery, 2022 - escholarship.org
A large variety of therapeutic products have been developed as vaccines or treatments of
COVID-19 infection. Meanwhile SARS-CoV-2 continues to mutate and spread. The severe …

Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial

YC Tao, EQ Chen - Current Stem Cell Research & Therapy, 2024 - ingentaconnect.com
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19), a serious challenge for human health. In …

Positive aspects, negative aspects and challenges associated with stem cell therapy for COVID-19: a mini-review

B Nagoba, A Gavkare, A Rayate… - Current Stem Cell …, 2022 - ingentaconnect.com
Like any other pandemic, Covid-19 scenario has also demanded effective treatment options.
The circumstances demand to utilize all the possible weapons in the armamentarium. There …

Challenges for mesenchymal stem cell-based therapy for COVID-19

C Li, H Zhao, B Wang - Drug Design, Development and Therapy, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) global pandemic continues and antiviral
agents and vaccines are currently under investigation. Mesenchymal stem cell (MSC)-based …

Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment

V Balaji Easwaran, S Satarker… - Current Stem Cell …, 2023 - ingentaconnect.com
Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in late 2019 with severe respiratory failure and organ …

Therapeutic and protective potential of mesenchymal stem cells, pharmaceutical agents and current vaccines against COVID-19

M Rasouli, F Vakilian, J Ranjbari - Current Stem Cell Research …, 2022 - ingentaconnect.com
It has been almost 18 months since the first outbreak of COVID-19 disease was reported in
Wuhan, China. This unexpected devastating phenomenon, raised a great deal of concerns …

[HTML][HTML] Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells—a literature review

K Sachdeva, A Kumar, S Mohanty - Stem Cell Investigation, 2021 - ncbi.nlm.nih.gov
Objective The objective of this review article is to outline the pathology, virology and
mechanism of severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) and to …

Diagnosis and treatment guidelines for mesenchymal stem cell therapy for coronavirus disease 2019 (Beijing, 2021)

X Ruonan, S Lei, X Wei-Fen, X Zhe… - Infectious Diseases & …, 2021 - mednexus.org
The coronavirus disease 2019 (COVID-19) can be caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, and has led to millions of deaths among …

Stem cell therapy potency in personalizing severe COVID-19 treatment

A Basiri, F Mansouri, A Azari, P Ranjbarvan… - Stem Cell Reviews and …, 2021 - Springer
Currently, there are no specific and efficient vaccines or drugs for COVID-19, particularly in
severe cases. A wide range of variations in the clinical symptoms of different patients …

[HTML][HTML] A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients

A Mahajan, S Bhattacharyya - Biomedical Journal, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by novel Severe Acute Respiratory
Syndrome-Coronavirus 2 (SARS-CoV2), is typically associated with severe respiratory …